Strober B, Augustin M, Tada Y, Garg A, Jullien D, Gottlieb A, Gudjonsson J, Hu N, Hofmann P, Thoma C, Marzano A. Effect of High-Dose Subcutaneous Spesolimab on Skin Manifestations: Results from the Pivotal Effisayil 2 Trial of Flare Prevention in Generalized Pustular Psoriasis. J of Skin [Internet]. 2024Mar.18 [cited 2024Jul.3];8(2):s371. Available from: https://jofskin.org/index.php/skin/article/view/2716